Michelle S Miller

10PUBLICATIONS
50CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 05, 2025
Computational design of potent and selective binders of BAK and BAX.

Stephanie Berger, Erinna F Lee, Tiffany J Harris

|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Brian J Mog, Nikita Marcou, Sarah R DiNapoli

|Apr 06, 2024
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells.

Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi

|Dec 13, 2023
Sequence differences between BAX and BAK core domains manifest as differences in their interactions with lipids.

Michelle S Miller, Angus D Cowan, Jason M Brouwer

|Aug 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.

Katharine M Wright, Sarah R DiNapoli, Michelle S Miller

|Mar 13, 2022
Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation.

Adeline Y Robin, Michelle S Miller, Sweta Iyer

Pageof 2

Frequent Collaborators

6 joint publications

Sandra B Gabelli

5 joint publications

Nickolas Papadopoulos

5 joint publications

Brian J Mog

5 joint publications

Sarah R DiNapoli